Additional file 2: Table S2. of The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry Akiko Sumi Udai Nakamura Masanori Iwase Hiroki Fujii Toshiaki Ohkuma Hitoshi Ide Tamaki Jodai-Kitamura Yuji Komorita Masahito Yoshinari Yoichiro Hirakawa Atsushi Hirano Michiaki Kubo Takanari Kitazono 10.6084/m9.figshare.5696515.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Table_S2_of_The_gene_treatment_interaction_of_paraoxonase-1_gene_polymorphism_and_statin_therapy_on_insulin_secretion_in_Japanese_patients_with_type_2_diabetes_Fukuoka_diabetes_registry/5696515 Clinical characteristics according to PON1 genotype. Data are expressed as mean ± SD, median (interquartile), and n (percentage). CVD: cardiovascular disease, OHA: oral hypoglycemic agents, α-GI: alpha-glucosidase inhibitor, DPP4-I: inhibitors of type 4 dipeptidyl peptidase* log-transformed for the statistical analysis. (DOCX 14 kb) 2017-12-12 05:00:00 Gene–treatment interaction PON1 Q192R polymorphism Statin therapy Insulin secretion